Secondary diabetes mellitus is frequently ignored in specialized literature. In this narrative
review, the main endocrinopathies accompanied by increased glycemic values are …

Glucagonoma syndrome is defined by the presence of an alpha‐cell secreting tumour of the
pancreas, elevated levels of glucagon, and a characteristic rash called necrolytic migratory …

Pancreatic neuroendocrine neoplasms (panNENs) are rare relatively malignancies that,
despite their frequently slow-growing pattern, have the ability to metastasize. Metastatic …

Glucagonoma is an extremely rare pancreatic α‑islet cell tumor and is often accompanied by
certain clinical symptoms including necrotizing migratory erythema (NME), diabetes, weight …

ABSTRACT Introduction: Neuroendocrine tumors (NETs) harbor somatostatin receptors and
there is a strong rationale for using somatostatin analogs (SSAs) for treatment of NETs …

Context Necrolytic migratory erythema (NME) occurs in approximately 70% of patients with
glucagonoma syndrome. Excessive stimulation of metabolic pathways by …

Background: Necrolytic migratory erythema (NME) is most commonly a paraneoplastic
condition. It is the dermatologic manifestation classically associated with glucagonoma …

Purpose: Glucagonoma is an extremely rare neuroendocrine tumor arising from pancreatic
islet cells. Although patients with glucagonoma manifest multiple typical symptoms, early …

Octreotide acetate, the active pharmaceutical ingredient in the long‐acting release (LAR)
drug product Sandostatin®, is a cyclic octapeptide that mimics the naturally occurring …

Glucagonomas are rare neuroendocrine neoplasms of the pancreas with malignant
potential. At present, their epidemiology is not entirely clear, so clinicians are not well …